Komori
Nozaki Insatsu Shigyo (7919) · RiskMitigated

Market Price Fluctuations in Investment Securities

First written in FY2017. 9 of 19 entries say "Materialised", first in FY2019-Q3. Latest entry: 2026-07-30.

19entries
10years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2017 – FY2018MaterialisedFY2019-Q3 – FY2021-Q2MaterialisedFY2022-Q3 – FY2023-Q12017: 120172018: 120182019: 220192020: 220202021: 120212022: 220222023: 320232024: 320242025: 220252026: 22026
Same theme, other companies
Valuation Losses Due to Declines in the Market Value of Securities HeldA theme 235 companies write about · 232 as a headwind · 3 as a tailwind

Nozaki Insatsu Shigyo moved to the "Worse" side of this theme in 2019, the same year as the typical company in this theme.

The whole theme swung hardest in 2019: 69 of 143 companies on the "Worse" side.

50 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 199 companies compared. The sentences above are computed from all 199.Comparing 200 of the theme's 237 threads.
Full recordFilings, disclosures and news, newest first
  1. 2026-07-30MitigatedEarnings

    「その他有価証券評価差額金 118,980 162,672」

    その他有価証券評価差額金が前期末から増加し、市場価格変動に伴う評価差額が改善している。
  2. FY2026MitigatedAnnual report

    「There were no applicable items during the current consolidated fiscal year.」

    The company did not recognise any impairment losses on investment securities during the year. The valuation difference on other securities also increased from ¥76.946 million at the end of the previous fiscal year to ¥118.980 million.
  3. FY2026-H1MitigatedAnnual report

    「Valuation difference on other securities △ ¥9.453 million ¥21.358 million」

    The valuation difference on other securities changed from a loss of ¥95 million in the same period of the previous year to a gain of ¥21 million in the interim period under review, indicating an improvement in valuation differences due to market price fluctuations.
  4. FY2025MaterialisedAnnual report

    「Valuation difference on other securities ¥79.994 million ¥76.946 million」

    The valuation difference on other securities decreased from ¥79.994 million at the end of the previous fiscal year to ¥76.946 million, resulting in a loss of ¥3.048 million in other comprehensive income for the consolidated fiscal year under review.
  5. FY2025-H1MaterialisedAnnual report

    「Other comprehensive income Valuation difference on other securities △ ¥1.433 million △ ¥9.453 million」

    The valuation difference on other securities changed from a loss of ¥1.433 million in the same period of the previous year to a loss of ¥9.453 million in the interim period under review, indicating that valuation differences due to market price fluctuations actually deteriorated.
  6. FY2024MitigatedAnnual report

    「There were no applicable items during the current consolidated fiscal year.」

    The company did not recognise any impairment losses on investment securities during the year. It also recognised a gain on sales of investment securities of ¥22.306 million.
  7. FY2024-Q3MaterialisedAnnual report

    「Valuation difference on other securities ¥5.554 million △ ¥9.742 million」

    The valuation difference on other securities changed from a gain of ¥5.554 million in the same period of the previous year to a loss of ¥9.742 million in the cumulative third quarter under review, quantitatively demonstrating a deterioration in valuation differences due to market price fluctuations.
  8. FY2024-Q2Recognition of Gains on Sales of Investment SecuritiesAnnual report

    「Gain on sales of investment securities - ¥22.306 million」

    The company recognised a gain on sales of investment securities of ¥22.306 million during the cumulative consolidated second quarter under review.
  9. FY2024-Q1MitigatedAnnual report

    「Other comprehensive income Valuation difference on other securities △ ¥4.603 million ¥8.555 million」

    The valuation difference on other securities changed from a loss of ¥4.603 million in the same period of the previous year to a gain of ¥8.555 million in the first quarter under review, indicating an improvement in valuation differences due to market price fluctuations.
  10. FY2023MitigatedAnnual report

    「There were no applicable items during the current consolidated fiscal year.」

    The company did not recognise any impairment losses on investment securities during the year, and the valuation losses and impairment losses recognised in the previous year did not continue into the current year.
  11. FY2023-Q1MaterialisedAnnual report

    「Valuation difference on other securities ¥1.259 million △ ¥4.603 million」

    The valuation difference on other securities changed from a gain of ¥1.259 million in the same period of the previous year to a loss of ¥4.603 million in the quarter under review, quantitatively demonstrating a deterioration in valuation differences due to market price fluctuations.
  12. FY2022-Q3MaterialisedAnnual report

    「Impairment loss on investment securities - ¥1.484 million」

    The company recognised an impairment loss of ¥1.484 million on investment securities, and the risk of market price fluctuations also materialised as an impairment loss during the cumulative third quarter under review.
  13. FY2022-Q2MitigatedAnnual report

    「Impairment loss on investment securities ¥3.759 million -」

    Although the company recognised an impairment loss of ¥3.759 million on investment securities in the same quarter of the previous year, the amount recognised was zero in the cumulative consolidated second quarter under review.
  14. FY2021-Q2MaterialisedAnnual report

    「Impairment loss on investment securities - ¥3.759 million」

    The company recognised an impairment loss of ¥3.759 million on investment securities, and the risk of market price fluctuations continued to materialise as an impairment loss.
  15. FY2020MaterialisedAnnual report

    「During the consolidated fiscal year, the company recognised an impairment loss of ¥2.698 million on shares classified as other securities.」

    The risk of fluctuations in the market prices of investment securities continued to materialise as impairment losses, and the company recognised an impairment loss of ¥2.698 million during the year.
  16. FY2020-Q1MaterialisedAnnual report

    「Impairment loss on investment securities ¥2.390 million ¥1.965 million」

    The company recognised an impairment loss of ¥1.965 million on investment securities, and the risk of market price fluctuations continued to materialise as an impairment loss.
  17. FY2019-Q3MaterialisedAnnual report

    「Impairment loss on investment securities - ¥3.634 million」

    The company recognised an impairment loss of ¥3.634 million on investment securities, demonstrating that the risk of market price fluctuations had materialised as an impairment loss. This is an actual occurrence quantified in the financial statements.
  18. FY2018RestatedAnnual report

    「Marketable securities, primarily shares in companies with which the company has business relationships, may be exposed to the risk of fluctuations in market prices.」

    The company reiterates the risk of fluctuations in market prices associated with its holdings of shares in companies with which it has business relationships.
  19. FY2017First statedAnnual report

    「Marketable securities, primarily shares in companies with which the company has business relationships, may be exposed to the risk of fluctuations in market prices.」

    The company holds shares in companies with which it has business relationships and states that they are exposed to the risk of fluctuations in market prices.
Moved together

"Year-on-Year Declines in Revenue and Profit" moved the same way as this thread, in the same document, in 8 of its 19 moves.

866655★123456
  1. ★This thread
  2. 1Year-on-Year Declines in Revenue and Profit8×
  3. 2Improving Equity by Strengthening the Earnings Base6×
  4. 3Rising Paper Stock Prices and Difficulty Passing Through Higher Costs6×
  5. 4Recovery in commercial-printing orders and growth in art-printing materials6×
  6. 5Work Improvements and Production Process Development, Returning to the Basics of Manufacturing5×
  7. 6Uncertainty over the outlook due to the Kumamoto Earthquake and sharp fluctuations in stock prices and exchange rates5×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Nozaki Insatsu Shigyo's next results are scheduled for 2026-10-29. Read the earnings preview It last moved in the Earnings of 2026-07-30: "Mitigated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Market Price Fluctuations in Investment Securities | Nozaki Insatsu Shigyo Co.,Ltd. (7919) | Komori